Get the Stockscreener App
45.63
1.57%
-0.6746
Collegium Pharmaceutical Inc stock is traded at $45.63, with a volume of 107.81K.
It is down -1.57% in the last 24 hours and down -4.08% over the past month.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
See More
Previous Close:
$46.30
Open:
$46.33
24h Volume:
107.81K
Relative Volume:
0.23
Market Cap:
$1.44B
Revenue:
$566.77M
Net Income/Loss:
$48.16M
P/E Ratio:
38.34
EPS:
1.19
Net Cash Flow:
$274.29M
1W Performance:
-8.56%
1M Performance:
-4.08%
6M Performance:
+49.37%
1Y Performance:
+59.18%
1-Day Range:
$45.48
$46.46
1-Week Range:
$45.48
$50.79
52-Week Range:
$23.23
$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Name
Collegium Pharmaceutical Inc
Sector
Phone
781-713-3699
Address
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Compare COLL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
45.63 | 1.46B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
125.47 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.02 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.66 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
491.72 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jan-10-25 | Upgrade | Needham | Hold → Buy |
| Jul-30-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jun-07-24 | Upgrade | Jefferies | Hold → Buy |
| May-10-24 | Downgrade | Needham | Buy → Hold |
| May-10-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-04-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-25-23 | Reiterated | Needham | Buy |
| May-02-23 | Resumed | Jefferies | Buy |
| Aug-08-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-15-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Aug-06-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-11-21 | Reiterated | H.C. Wainwright | Buy |
| Jul-14-20 | Initiated | BWS Financial | Sell |
| May-27-20 | Initiated | Guggenheim | Neutral |
| Feb-19-20 | Resumed | Jefferies | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| May-03-19 | Resumed | H.C. Wainwright | Buy |
| Apr-12-19 | Resumed | Janney | Buy |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Jan-16-19 | Reiterated | Needham | Buy |
| Mar-08-18 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-18 | Reiterated | Needham | Buy |
| Dec-05-17 | Reiterated | Needham | Buy |
| Sep-11-17 | Initiated | H.C. Wainwright | Buy |
| May-11-17 | Reiterated | Needham | Buy |
| Sep-13-16 | Initiated | Gabelli & Co | Buy |
| Jun-01-15 | Initiated | Jefferies | Buy |
| Jun-01-15 | Initiated | Needham | Buy |
| Jun-01-15 | Initiated | Piper Jaffray | Overweight |
View All
Collegium Pharmaceutical Inc Stock (COLL) Latest News
Collegium Pharmaceutical (NASDAQ:COLL) Stock Price Down 5%Here's What Happened - MarketBeat
Collegium Announces the Closing of $980 Million Syndicated Credit Facility - The Globe and Mail
Liquidity Mapping Around (COLL) Price Events - Stock Traders Daily
Collegium Pharmaceutical Closes New $980 Million Credit Facility - TipRanks
Collegium Pharmaceutical Closes $980 Million Syndicated Credit Facility - marketscreener.com
Collegium Pharmaceutical Signs Credit Agreement With Truist Bank - TradingView — Track All Markets
Collegium Pharmaceutical, Inc. Announces the Closing of $980 Million Syndicated Credit Facility - marketscreener.com
Pacer Advisors Inc. Sells 87,066 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
2 Reasons to Avoid COLL and 1 Stock to Buy Instead - Yahoo Finance
Collegium Pharmaceutical stock hits all-time high at 49.92 USD By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 12-Month HighStill a Buy? - MarketBeat
Collegium Pharmaceutical stock hits all-time high at 49.92 USD - Investing.com India
Is Collegium Pharmaceutical Inc a good long term investmentMarket Rumors and News & High Yield Trading Plans - earlytimes.in
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - sharewise.com
Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year? - Yahoo Finance
Assenagon Asset Management S.A. Purchases 92,898 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Can Collegium Pharmaceutical Inc. stock sustain free cash flow growthTrade Entry Summary & Daily Profit Maximizing Trade Tips - bolumsonucanavari.com
Will Collegium Pharmaceutical Inc. stock benefit from commodity pricesInsider Buying & Advanced Technical Analysis Signals - Улправда
How rising interest rates impact Collegium Pharmaceutical Inc. stockWeekly Investment Report & Safe Capital Investment Plans - Улправда
Is Strong Q3 Beat And Higher Guidance Altering The Investment Case For Collegium Pharmaceutical (COLL)? - Yahoo Finance
Can Collegium Pharmaceutical Inc. stock beat market expectations this quarterQuarterly Portfolio Summary & Free Weekly Chart Analysis and Trade Guides - Улправда
Understanding the Setup: (COLL) and Scalable Risk - Stock Traders Daily
Published on: 2025-12-19 17:44:17 - DonanımHaber
Is Collegium Pharmaceutical Inc. stock positioned for digital transformationJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - Улправда
3 Unpopular Stocks We Find Risky - Finviz
Will Collegium Pharmaceutical Inc. stock deliver strong dividend growthMarket Volume Report & Comprehensive Market Scan Reports - DonanımHaber
Will Collegium Pharmaceutical Inc. stock benefit from infrastructure spendingJuly 2025 Sentiment & High Conviction Investment Ideas - DonanımHaber
How Collegium Pharmaceutical Inc. stock performs in weak economy - Улправда
Trade Recap: Will Collegium Pharmaceutical Inc. stock benefit from infrastructure spending2025 Support & Resistance & Reliable Intraday Trade Plans - DonanımHaber
Collegium Pharmaceutical Earnings Notes - Trefis
Can Collegium Pharmaceutical Inc. stock outperform in 2025 bull marketJuly 2025 Movers & Long Hold Capital Preservation Tips - Улправда
Best Value Stocks to Buy for Dec. 18 - sharewise.com
Strong Q3 Beat and Guidance Upside Might Change The Case For Investing In Collegium Pharmaceutical (COLL) - simplywall.st
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment? - 富途牛牛
Collegium Pharmaceutical (COLL): Valuation Check After Strong Revenue Beat and Upgraded Full-Year Performance - simplywall.st
Collegium Pharma spikes after 2025 outlook - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year HighShould You Buy? - MarketBeat
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) - Yahoo Finance
Needham Upgrades Collegium Pharmaceutical (COLL) - MSN
Collegium Pharmaceutical Inc 354 Stock Analysis and ForecastMarket Volatility Update & Exceptional Return Growth - earlytimes.in
Insider Selling: Collegium Pharmaceutical (NASDAQ:COLL) EVP Sells 17,600 Shares of Stock - MarketBeat
Collegium Pharmaceutical stock hits all-time high at 49.11 USD By Investing.com - Investing.com Canada
Collegium Pharmaceutical stock hits all-time high at 49.11 USD - Investing.com
1 Growth Stock Set to Flourishand 2 Facing Challenges - The Globe and Mail
Collegium pharmaceutical EVP Dreyer sells $847k in stock - Investing.com India
Collegium pharmaceutical EVP Dreyer sells $847k in stock By Investing.com - Investing.com Australia
Collegium Pharmaceutical Inc Stock (COLL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Collegium Pharmaceutical Inc Stock (COLL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dreyer Scott | EVP & Chief Commercial Officer |
Dec 08 '25 |
Option Exercise |
15.90 |
17,600 |
279,840 |
121,213 |
| Dreyer Scott | EVP & Chief Commercial Officer |
Dec 08 '25 |
Sale |
48.17 |
17,600 |
847,855 |
103,613 |
| Balice-Gordon Rita J. | Director |
Dec 05 '25 |
Sale |
47.03 |
3,650 |
171,673 |
52,629 |
1.43%
2.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):